Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 667 of 1,261
  1. US 9486509

    Compositions and methods for preparing a subject for organ or non-organ implantation

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  2. US 9486502

    Methods of administering interferon gamma to absorb fluid from the subretinal space

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  3. US 9486489

    Method for producing dry extracts

    BIONORICA SE · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  4. US 9486481

    Method of modulating fatty acid mobilization and oxidation

    Reoxcyn Discoveries Group, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  5. US 9486451

    Abuse resistant pharmaceutical compositions

    RECRO GAINESVILLE LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  6. US 9486456

    Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof

    The Board of Regents of the University of Texas System · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  7. US 9486446

    Orally disintegrating solid preparation

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  8. US 9486424

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  9. US 9486423

    Redox-directed chelators targeting intracellular metal ions

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  10. US 9486411

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  11. US 9486414

    Method for delivering liraglutide preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  12. US 9486401

    Use of cellular extracts for skin rejuvenation

    REGENICS AS · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  13. US 9487535

    Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted
  14. US 9480785

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  15. US 9481689

    sGC stimulators

    IRONWOOD PHARMACEUTICALS, INC. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  16. US 9481677

    Biaryl ether sulfonamides and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  17. US 9480725

    Fermented wheat germ proteins (FWGP) for the treatment of cancer

    The Regents of the University of California · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  18. US 9480677

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  19. US 9480673

    Composition and method for treating neurodegenerative disease

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  20. US 9481866

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  21. US 9481888

    Recombinant bacterium and methods of antigen and nucleic acid delivery

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  22. US 9481877

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  23. US 9481894

    Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted
  24. US 9481717

    Lectins and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.